Cover Image

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients

BackgroundWe explored the therapeutic and prognostic effect of YAP/TAZ intensityinHER2-positive breast cancer patients. We also investigated the relationship between YAP/TAZ expression and Trastuzumab-resistance.MethodsWe collected clinicopathological information from 397 cases. We evaluated therape...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia-qi Yuan (Author), Nian-hua Ding (Author), Zhi Xiao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hydrostatic Pressure Modulates Intervertebral Disc Cell Survival and Extracellular Matrix Homeostasis via Regulating Hippo-YAP/TAZ Pathway
by: Yiyang Wang, et al.
Published: (2021)

An engineered mayhem: YAP/TAZ mechanosignaling and hepatocarcinogenesis in NAFLD
by: Gyorgy Baffy
Published: (2021)

The Hippo Coactivator TAZ Exacerbates Cisplatin-Induced Acute Renal Injury
by: Xian Xue, et al.
Published: (2024)

Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
by: Meijia Qian, et al.
Published: (2021)

The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis
by: Li M, et al.
Published: (2024)

Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
by: Aviral Kumar, et al.
Published: (2024)

Direct YAP/TAZ-TEAD inhibitor paves the way toward realizing cancer mechanomedicine
by: Kostas A. Papavassiliou, et al.
Published: (2024)

Tetramethylpyrazine Ameliorates Peritoneal Angiogenesis by Regulating VEGF/Hippo/YAP Signaling
by: Xiaolin Zhu, et al.
Published: (2021)

Alteration in branching morphogenesis via YAP/TAZ in fibroblasts of fetal lungs in an LPS-induced inflammation model
by: Hung-Shuo Ko, et al.
Published: (2023)

Expression of Yap Signaling Hippo Pathway in Cervical Pre-cancerous Lesions and Cervical Cancer
by: M Masrur Rizal, et al.
Published: (2024)

Piezo 1 activation facilitates cholangiocarcinoma metastasis via Hippo/YAP signaling axis
by: Biqiang Zhu, et al.
Published: (2021)

Cinobufacini injection suppresses the proliferation of human osteosarcoma cells by inhibiting PIN1-YAP/TAZ signaling pathway
by: Yuru Chen, et al.
Published: (2023)

Nephroprotective Effect of Adropinin Against Streptozotocin-Induced Diabetic Nephropathy in Rats: Inflammatory Mechanism and YAP/TAZ Factor
by: Guo L, et al.
Published: (2021)

Noncanonical Wnt5a Signaling Suppresses Hippo/TAZ-Mediated Osteogenesis Partly Through the Canonical Wnt Pathway in SCAPs
by: Fu Y, et al.
Published: (2022)

Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
by: Jiangping Yang, et al.
Published: (2022)

Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
by: Quan Liang, et al.
Published: (2016)

GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
by: Wuxiyar Otkur, et al.
Published: (2023)

Piezo1 activation facilitates ovarian cancer metastasis via Hippo/YAP signaling axis
by: Yanjie Xiong, et al.
Published: (2022)

Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis
by: Wu Y, et al.
Published: (2018)

Incidental cytokeratin-positive interstitial reticulum cell tumor of the lymph node accompanied by breast cancer: Status of YAP/TAZ expression in tumor cells
by: Chiemi Saigo, et al.
Published: (2021)

Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer
by: Feng Guan, et al.
Published: (2024)

Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer
by: Chenxi Zhao, et al.
Published: (2020)

Emodin in Rheum undulatum inhibits oxidative stress in the liver via AMPK with Hippo/Yap signalling pathway
by: Eun Hye Lee, et al.
Published: (2020)

Microtubule stabilization promotes the synthesis of type 2 collagen in nucleus pulposus cell by activating hippo-yap pathway
by: Xin Zhang, et al.
Published: (2023)

PADI6 Regulates Trophoblast Cell Migration-Invasion Through the Hippo/YAP1 Pathway in Hydatidiform Moles
by: Huang B, et al.
Published: (2021)

Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine
by: Sadeghi S, et al.
Published: (2014)

Acute Local Spontaneous and Profuse Gingival Hemorrhage during Neoadjuvant Treatment with Paclitaxel and Trastuzumab
by: Nima D. Sarmast, et al.
Published: (2016)

Age-Related Downregulation of CCN2 Is Regulated by Cell Size in a YAP/TAZ-Dependent Manner in Human Dermal Fibroblasts: Impact on Dermal Aging
by: Zhaoping Qin, et al.
Published: (2022)

FTO attenuates the cytotoxicity of cisplatin in KGN granulosa cell-like tumour cells by regulating the Hippo/YAP1 signalling pathway
by: Rongli Wang, et al.
Published: (2024)

Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling
by: Ting Chen, et al.
Published: (2021)

Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway
by: Wanyun Zuo, et al.
Published: (2021)

Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study
by: Steven Simoens, et al.
Published: (2021)

Whether HER2-positive non-breast cancers are candidates for treatment with Ado-trastuzumab emtansine?
by: Azadeh Moghaddas, et al.
Published: (2016)

Novel roles of the junctional protein associated with coronary artery disease in regulating Hippo‐YAP signalling axis to improve liver regenerative potential
by: Eltyeb Abdelwahid
Published: (2024)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
by: Rui Jiang, et al.
Published: (2023)

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer
by: Miaomiao Jia, et al.
Published: (2024)

Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
by: Zhong W, et al.
Published: (2023)

Combined trastuzumab and radiation therapy for HER2-positive uterine serous carcinoma: A case report
by: SPH Mao, et al.
Published: (2023)

Adverse reactions for the use of the monoclonal trastuzumab antibody in the treatment of patients with HER2 positive breast cancer
by: Iago Dilion Lima Cavalcanti, et al.

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer
by: Li S, et al.
Published: (2018)